WO1998014239A1 - An implantable medical device comprising an accelerometer - Google Patents

An implantable medical device comprising an accelerometer Download PDF

Info

Publication number
WO1998014239A1
WO1998014239A1 PCT/SE1997/001580 SE9701580W WO9814239A1 WO 1998014239 A1 WO1998014239 A1 WO 1998014239A1 SE 9701580 W SE9701580 W SE 9701580W WO 9814239 A1 WO9814239 A1 WO 9814239A1
Authority
WO
WIPO (PCT)
Prior art keywords
signal
housing
heart
values
status
Prior art date
Application number
PCT/SE1997/001580
Other languages
French (fr)
Inventor
Kenth Nilsson
Original Assignee
Pacesetter Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacesetter Ab filed Critical Pacesetter Ab
Priority to EP97943257A priority Critical patent/EP0936936B1/en
Priority to US09/147,999 priority patent/US6044299A/en
Priority to DE69726447T priority patent/DE69726447T2/en
Publication of WO1998014239A1 publication Critical patent/WO1998014239A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36514Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
    • A61N1/36542Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by body motion, e.g. acceleration

Definitions

  • the present invention relates to an implantable medical device, in particular an implantable heart stimulator, in accordance with the preamble of claim 1.
  • variable rate pacemaker having a piezo-electric element which, when subjected to motion, vibrates due to the resulting strain upon it to ! 0 provide alternating voltage. Said voltage is used for varying the rate of the pacemaker which consequently is varied in response to the physical activity of the pacemaker patient.
  • Pacemakers commonly uses electrodes for sensing electrical signals related to heart activity. Alternatively a pacemaker may use sounds related to heart activity for monitoring
  • US-patent 5.447,523 discloses a pacemaker including a microphone for sensing acoustic heart signals.
  • the microphone includes a sensor responsive to relative movement between two portions of the pacemaker housing caused by heart movements.
  • the sensed signals are filtered and systolic time intervals (STI) are extracted from it.
  • STI systolic time intervals
  • amplitude of the detected sound signal is small since only the difference in movement between the two housing portions is detected.
  • the quality of the sensed sound signal varies from patient to patient depending on the bodily constitution of the patient.
  • a primary object of the invention is to solve the abovementioned problem that the quality of the sensed sound signal varies from patient to patient depending on the bodily ) constitution of the patient.
  • a second object is to solve the abovementioned problem related to the fact that the systolic time intervals suffer from lack of sensitivity as control parameters for a pacemaker.
  • a third object of the present invention also relates to the problem of providing a heart stimulator having means for generating suitable stimulation signals without the need for electrodes for electrically sensing heart activity.
  • a status value related to heart activity is established as a quotient between two parameter values.
  • the establishing of quotients leads to elimination of the disadvantageous dependence of measured values on the bodily 10 constitution of the patient. Furthermore the quotient values are less dependent on the position of the patients body than are the parameter values as such.
  • I ⁇ direction of sensitivity substantially perpendicular to the plane of the disc shaped housing of the implantable device.
  • the device according to the invention can of course be used to measure physical activity in " ) a rate responsive pacemaker.
  • physical activity is normally represented by a vibration frequency of less than 20 Hz and heart sound generated vibrations has normally a frequency of more than 20 Hz.
  • the device is easily vibrated in response to vibrations in the tissue in which it is placed when implanted, since it preferably has a weight below 20 grams. This feature, particularly
  • a very advantageous placement of the device, giving the highest sensitivity to heart sound, is to place it directly on the heart where it can be placed either between the epicardium and the pericardium or on the pericardium.
  • an implanted heart sound detector detects and registrates heart sounds with a greater accuracy than a conventionel heart stethoscope does, giving very valuable information from a diagnostic viewpoint leading to a better security for the diagnosis for patients in different situations.
  • Fig 1A shows a schematic block diagram of a first preferred embodiment of the invention.
  • Fig IB is a perspective view of a heart stimulator shown implanted in association with a heart for pacing.
  • Fig 2 is a sectional side view of an embodiment of a detector, which may be used in the device according to Fig IB, as seen in the direction of vector x in Fig IB.
  • Fig 3 is a sectional side view of an alternative embodiment of the detector.
  • Fig 4 is a frequency/amplitude diagram illustrating the sensitivity of the detector shown in
  • Fig 5 is a frequency /amplitude diagram illustrating the method of dividing the sensor signal into a number of frequency bands.
  • Figure 6A shows a schematic block diagram of a second embodiment of the heart stimulator according to the invention.
  • Figure 6B shows an extracorporeal signal processing device adapted to communicate with the pacemaker according to Figure 6A.
  • Figure 7 is a time/amplitude diagram illustrating parameter values in the shape of sampled values indicating the temporal progression of the 50 hertz component of a sensor signal. Detailed description of the embodiments
  • Fig 1A shows a schematic block diagram of a first embodiment of an implantable device 10 for providing stimulation signals and for detecting signals relating to heart activity of a patient.
  • the device 10 comprises an accelerometer 20, which is mechanically connected to the housing 30 of the stimulator 10, as will be described in detail in connection with Figures 2 and 3.
  • the accelerometer 20 senses the vibrations of the pacemaker housing 30.
  • the accelerometer 20 and the housing 30 functions together as a microphone for acoustic waves corresponding to heart valve sounds and heart muscle movements.
  • the accelerometer produces an vibration signal S comprising information about the activity of the heart.
  • the signal is processed such that a plurality of parameter values are generated.
  • the parameter values it is possible to determine the medical status of the heart.
  • the accelerometer 20 supplies the vibration signal S to a processing unit 40, which includes a plurality of bandpass filters 50 for dividing the electrical signal S into a plurality of frequency bands B, - B n , the frequency bands having the center frequency at e.g. 50, 100, 200 and 400 Hz. However other center frequencies, both higher and lower ones are possible depending on the frequency of interest.
  • a unit 60 is arranged for measuring the energy P, - P n in each frequency band, for generating a reference value P tot comprising the total amount of energy calculated as the sum of P, - P n , and for dividing each individual energy value P, - P n with the reference value so as to achieve a number of parameter values C, - C n .
  • the energy values P, - P n are sampled with a sampling frequency f s , which may be, for example, 2 kHz. Accordingly, n digital energy signals will be generated, each signal indicating the actual sensed energy within a specified frequency band.
  • the parameter values C, - C n are supplied to a control unit 100 where a set of status values are determined as a quotient between two simultaneously generated parameter values.
  • the control unit is in Fig. 1 shown as a separate unit but could as well be an integral part of the processing unit 40.
  • Each parameter value constitutes a value indicative of the amount of vibration of the stimulator housing in the respective frequency region.
  • Q 2 CV C 3
  • the parameter values forming the quotient e.g. C, and C 2
  • which conditions to be studied, e.g. valve sounds and heart muscle movements from heart tissue close to the pacemaker housing.
  • the heart's contractility is for example reflected by the frequency content of the heart sound in the way that a heavier heart contraction is shown as a frequency shift towards higher frequencies.
  • the normal values for the quotients constitute reference status values in response to which a first operational mode of the heart stimulator may be suitable. Such normal values are stored in a memory means 70.
  • the control unit operates to monitor the new status values in realtime.
  • I By means of I ) registering a predefined deviation from the stored reference status values another operational mode for the heart stimulator can be activated.
  • a stimulation control signal CS is generated in response to these comparisons made in the control unit 100.
  • the heart's contractility can be determined from the detected heart sound, and then also other parameters related to the contractility, e.g. the stroke volume, blood pressure (P) '0 and dP/dt. These parameters can be used by the control unit to decide which operational mode the heart stimulator should work in. Using one or many of these parameters as a control parameter for a pacemaker is well known by a person skilled in the art of pacemakers and is therefore not described in this application.
  • the parameter values C, - C n can also be supplied to the memory means 70 for storage in consecutive time order and to a limit value sensor 80.
  • the limit value sensor 80 is operative to provide comparisons between the actual parameter values received on a first input 90 from the signal processing unit 40 with reference parameter values stored in the memory means 70. According to one version of the invention the limit value sensor 80 generates a
  • the limit value sensor compares the actual parameter value C, with the moving average C, a and if one or several of the actual parameter values C, - C ⁇ deviate by more than a predetermined amount from the corresponding moving average the limit value sensor 80 generates an alarm signal L.
  • the alarm signal L is supplied to an alarm transmitter 95.
  • the alarm signal L may be stored in the memory means 70 so as to be readable for example by means of telemetry at a later point in time when the patient visits a doctor.
  • the signal processing unit 40 also provides a continuous energy signal having an amplitude corresponding to the actual energy within each respective frequency band. Accordingly the signal processing unit provides n energy signals P cl - P cn to a control unit 100.
  • the control unit 100 operates to generate a stimulation control signal in response to the energy signals.
  • the stimulator control signal CS is provided to a stimulation signal generator 110.
  • signal generator 110 comprises a signal output 120 and a reference output 130.
  • the signal output 120 is coupled to a conductor 140 in an implantable lead 150 having a tip electrode 160 which is connected to the conductor 140.
  • the lead 150 also has a ring electrode 170 which is connected to a conductor 180 in the lead 150.
  • the conductor 180 is coupled to the reference output 130. Accordingly the stimulator signal potential provided between
  • the output 120 is coupled to a lead having only one electrode and the reference terminal 130 is coupled to the housing 30 which is electrically conductive and which functions as a reference electrode.
  • Fig IB there is shown a simplified representation of two ways that an implanted pacemaker 10 may make electrical contact with the heart of the patient.
  • Fig IB reflects the use of a bipolar lead 150 being directed into the right atrium 190 of the heart.
  • the distal tip electrode 160 is typically placed in a cavity of the right atrium 190 referred to
  • the housing 30 of the stimulator device 10 is substantially disc shaped with one side wall 210 positioned in the plane defined by the two orthogonal axes x and y in Fig IB.
  • the side wall 210 has an area of preferably 500 mm 2 .
  • Figs 2 and 3 show two alternative embodiments of the accelerometer 20 in the device according to the invention.
  • Both of the shown embodiments comprise two elongated members of piezoelectric material 300 and 310 which are attached to each other and arranged in an aligned fashion next to each other so as to form an elongated sensor body.
  • One end of the elongated sensor body is attached to the housing 30 (Fig 1A and Fig IB) by fastening means 320.
  • the direction of elongation of the elongated sensor body 300. 310 is substantially parallel to the wall 210 of the housing 30.
  • the elongated sensor body also has a moveable end 325, which is provided with a weight 330.
  • the inertia of the weight 330 will cause the sensor body to bend in response to accelerations of the housing 30. Accordingly, when the stimulator device is implanted in the body of the patient in a manner shown in Fig IB the free end 325 of the sensor body will move in a direction substantially parallel with the direction of the normal z to the surface of the wall 210.
  • the elongated members 300 and 310 are polarized in substantially opposing directions as indicated by arrows 340 and 350 in Fig 2.
  • an electrical signal S is provided between terminals 360 and 370.
  • the two elongated elements 300 and 310 are polarized in the same direction as indicated by arrows 380 and 390.
  • a first electric sensor signal is provided between terminals U 3 and U 4 while a second electric signal is provided between terminals U 4 and U 5 .
  • the two signals are transformed into one sensor signal S.
  • the electrical vibration signal S is divided into one signal for each frequency band as described above.
  • the accelerometer shown in Figs 2 and 3 has a sensitivity of about 100 millivolts per g, that is roughly 10 millivolts per ms '2 for vibrations having a frequency between 20 hertz and 600 hertz.
  • a typical frequency response curve for an accelerometer according to Fig 2 is shown in Fig 4. ' )
  • Locating the accelerometer 20 in contact with the housing 30 enables the accelerometer to provide a sensor signal in response to the movements of the stimulator 10. This means that the vibration signal S depends on the vibrations of the heart stimulator 10.
  • the stimulation device 10 when implanted, functions to measure the activity of the heart of the patient by sensing mechanical vibrations transmitted by body tissue to the housing of the device 10.
  • a fundamental problem related to all measurements is to minimize the influence of the measurement tool on the object to be measured. The inventor realized that in the case of accurately measuring vibrations in body tissue, this problem is transformed
  • Tests for determining the influence of the weight of the stimulator 10 on the sensitivity indicate that when the weight of the stimulator 10 is below 50 grams the sensitivity reaches '0 acceptable values.
  • the sensitivity is particularly favourable when the weight of the stimulator 10 is below 20 grams.
  • the stimulator 10 has a weight W in the range from 13 to 17 grams.
  • Tests for determining the influence of the disc-shaped side wall area of the stimulator 10 on ⁇ ⁇ ) the sensitivity indicate that when the side wall area of the stimulator 10 is below 1500 mm 2 for adults the sensitivity reaches favourable values.
  • the measurement sensitivity to high frequency vibrations, i.e. above 400 Hz, increases when the side wall area is decreased.
  • the stimulator device 10 has a side wall area of 500 mm 2 for adults.
  • the results of the tests indicate that the vibration signal S is advantageously accurate when the quotient of the weight W and the side wall area has a value below 0.05 g/mm 2 . for adults provided that the side wall area is kept below 1000 mm 2 .
  • a plurality of bandpass filters 50 are used for dividing the vibration signal S into a plurality of indicator signals S, - S n .
  • Each indicator signal has a bandwidth corresponding to the three dB bandwidth of the corresponding bandpass filter.
  • the full lines illustrates the frequency response for the filters FI - Fn, having bandwidths B, - B n .
  • the number of frequency bands is arbitrary but there should be at least three frequency bands. All frequency bands are within the frequency range where vibration signals are related to heart sound. According to a preferred embodiment the frequency range of the vibration signal S is between 0.2 hertz to 1000 hertz.
  • FIG. 6A A block diagram of a pacemaker body including electronic circuitry in accordance with a second preferred embodiment of the invention is shown in Figure 6A.
  • the pacemaker 10 comprises a hermetically sealed housing 30.
  • the pacemaker includes among other things a microprocessor 400 which is coupled to a read only memory, ROM, 410 and a read/write- memory. RAM, 420 via data busses 430, 440 and address busses 450, 460. There is also a lead 470 from the microprocessor 400 to the RAM 420 for setting the RAM 420 in a selected write mode or a selected read mode.
  • a computer program is stored in the ROM 410. and by means of this program the function of the pacemaker 10 is controlled.
  • the microprocessor 400 executes a certain function it is to be understood that the microprocessor executes a certain part of the program stored in the memory 410 using data stored in the memory 420.
  • a clock signal generator 480 provides a clock signal to the microprocessor and also thereby provides a time reference for the pacemaker.
  • the microprocessor 400 comprises a plurality of input/output terminals 490 coupled to two signal channels 500, 510.
  • the channel 500 is an output channel suitable for providing stimulation pulses to the heart.
  • the channel 500 ' SO comprises a stimulation pulse generator 512 having an output U,.
  • the pulse generator 512 is coupled to a corresponding output from the microprocessor 400 via a conductor 520, and the pulse generator 512 is arranged to produce a stimulation pulse in response to a signal provided from the output of the microprocessor.
  • Digital data for determining for example the shape of the stimulation pulse, such as the amplitude and the duration is provided to the pulse generator 512 via a lead 530 from the microprocessor 400.
  • the channel 510 comprises an analogue-to-digital (A/D) signal converter 540 having an input I, for receiving an electrical signal corresponding to a detectable activity from the accelerometer 20.
  • the output of the A/D converter provides a digital signal S d which is provided to a corresponding input of the microprocessor 400 via a databus.
  • the pacemaker 10 also comprises a first connector means having a socket 550 for mating with a corresponding second connector means provided at one end of an implantable lead, such as the above described lead 150, see Fig IB.
  • the socket 550 comprises a pin socket 560 and a connector ring 570.
  • the microprocessor 400 is coupled to a telemetric device 600 capable of transmitting and receiving data.
  • the telemetric device 600 comprises an antenna 610 for communicating with a corresponding extracorporeal telemetric device.
  • Figure 6B shows an extracorporeal data processing arrangement having an antenna 620 10 coupled to a telemetric device 630 for enabling communication with an implanted telemetric device such as the above described device 600.
  • the telemetric device 630 is coupled to a computer unit 640 comprising a data processing unit 650, an input/output device 660. such as a keyboard, and an output device 670 such as a screen.
  • the microprocessor can establish an amplitude value for a chosen frequency at a particular point in time.
  • These consecutive values are represented in fig 7 as V, 50 , V 2 50 , V 3 50 , V 4 50 ... V N 50 .
  • a set of amplitude values are established for the same points of time for the following frequency components: 100, 200 and 400 hertz.
  • Each amplitude value constitutes a parameter value indicative of the amount of vibration of the stimulator housing in the respective frequency region.
  • the heart of the patient is healthy there is a certain relation between the amplitudes in two different frequency regions. Accordingly a typical value for the quotient
  • I " 1 :400.50 * 1,40 ⁇ / * 1,50 when the patient ' s heart is healthy will be altered to another value indicative of different heart conditions, e.g. valve sounds and heart muscle movements from heart tissue close to the pacemaker housing, if the patient's heart condition changes.
  • the normal values for the quotients constitute reference status values in response to which a first operational mode of the heart stimulator may be suitable. Such normal values are stored in the memory means 410 or 420, see Fig 6A.
  • the processor operates to monitor the new status values in realtime. By means of . ' , ' registering a predefined deviation from the stored reference status values another operational mode for the heart stimulator can be activated.
  • the registered status values may be transmitted to the extracorporeal data processing arrangement 640, cf. Fig 6B.
  • the parameter values • ) and the status values may be a useful information for helping a doctor in establishing the type of heart condition of a patient.

Abstract

The invention relates to an implantable medical device comprising a housing (30) and an accelerometer means (20) adapted for detecting vibrations of said housing. The accelerometer means (20) provides a vibration signal (S, Sd) in response to said detected vibrations to a signal processing unit (40; 400) having at least one input for receiving the vibration signal (S, Sd), and at least one output for providing status values (Q1, Q2, ..., QN) related to heart activity. The signal processing unit (40; 400) is set up to simultaneously generate for each of at least two defined frequency ranges (B1, B2, ..., BN) a parameter value (C1, C2, ..., CN; V1,50, ..., V1,400) indicative of a defined quantity of the input signal, e.g. related to the amplitude or the energy of the input signal. The signal processing unit further being set up to determine at least one status value (Q1, Q2, ..., QN) in response to at least two parameter values. Said status values can be used inter alia as a control signal for a rate responsive pacemaker.

Description

AN IMPLANTABLE MEDICAL DEVICE COMPRISING AN ACCELEROMETER
Technical field of the invention The present invention relates to an implantable medical device, in particular an implantable heart stimulator, in accordance with the preamble of claim 1.
Description of related art
From US-patent 4,140,132 a variable rate pacemaker is known having a piezo-electric element which, when subjected to motion, vibrates due to the resulting strain upon it to ! 0 provide alternating voltage. Said voltage is used for varying the rate of the pacemaker which consequently is varied in response to the physical activity of the pacemaker patient.
Pacemakers commonly uses electrodes for sensing electrical signals related to heart activity. Alternatively a pacemaker may use sounds related to heart activity for monitoring
I ) heart activity. US-patent 5.447,523 discloses a pacemaker including a microphone for sensing acoustic heart signals. The microphone includes a sensor responsive to relative movement between two portions of the pacemaker housing caused by heart movements. The sensed signals are filtered and systolic time intervals (STI) are extracted from it. The systolic time intervals are used as reference quantities for the stimulation pulse rate. The
'!) amplitude of the detected sound signal is small since only the difference in movement between the two housing portions is detected. The quality of the sensed sound signal varies from patient to patient depending on the bodily constitution of the patient. These limitaions need to be considered when using this prior art sensor signal for controlling a pacemaker. Furthermore, the systolic time intervals suffer from lack of sensitivity as control parameters
1 1 for a pacemaker.
Summary
A primary object of the invention is to solve the abovementioned problem that the quality of the sensed sound signal varies from patient to patient depending on the bodily ) constitution of the patient.
A second object is to solve the abovementioned problem related to the fact that the systolic time intervals suffer from lack of sensitivity as control parameters for a pacemaker. A third object of the present invention also relates to the problem of providing a heart stimulator having means for generating suitable stimulation signals without the need for electrodes for electrically sensing heart activity.
These objects are achieved by a device according to claim 1.
Thus, according to the inventive device a status value related to heart activity is established as a quotient between two parameter values. The establishing of quotients leads to elimination of the disadvantageous dependence of measured values on the bodily 10 constitution of the patient. Furthermore the quotient values are less dependent on the position of the patients body than are the parameter values as such.
According to a preferred embodiment of the device according to the invention the sensor signal is generated by a sensor means including an accelerometer having a primary
I ι direction of sensitivity substantially perpendicular to the plane of the disc shaped housing of the implantable device. This leads to an advantageously high sensitivity to heart vibrations, when the device is implanted in a subject's body as the direction of sensitivity then coincides with the direction from the device to the heart. This directivity of the sensor device also has the advantage of reducing the sensitivity to noise and tissue vibrations in
JP other directions than those falling within the direction of sensitivity. Thereby the quality of the parameter signals and status signals is improved.
Externally generated vibrations, e.g. due to physical activity of the patient, are small in comparison with the heart vibrations. The device according to the invention can of course be used to measure physical activity in ") a rate responsive pacemaker.
Generally, physical activity is normally represented by a vibration frequency of less than 20 Hz and heart sound generated vibrations has normally a frequency of more than 20 Hz. The device is easily vibrated in response to vibrations in the tissue in which it is placed when implanted, since it preferably has a weight below 20 grams. This feature, particularly
!C in combination with the above described directivity of the sensor, leads to highly accurate status signals being provided. A very advantageous placement of the device, giving the highest sensitivity to heart sound, is to place it directly on the heart where it can be placed either between the epicardium and the pericardium or on the pericardium.
Furthermore an implanted heart sound detector detects and registrates heart sounds with a greater accuracy than a conventionel heart stethoscope does, giving very valuable information from a diagnostic viewpoint leading to a better security for the diagnosis for patients in different situations.
I υ. Further features and embodiments of the device according to the invention are disclosed in the rest of the claims.
Brief description of the drawings
For easier understanding of the present invention it will be described by means of examples and with reference to the accompanying drawings, on which
Fig 1A shows a schematic block diagram of a first preferred embodiment of the invention.
Fig IB is a perspective view of a heart stimulator shown implanted in association with a heart for pacing.
Fig 2 is a sectional side view of an embodiment of a detector, which may be used in the device according to Fig IB, as seen in the direction of vector x in Fig IB.
Fig 3 is a sectional side view of an alternative embodiment of the detector.
Fig 4 is a frequency/amplitude diagram illustrating the sensitivity of the detector shown in
Fig 2 or 3.
Fig 5 is a frequency /amplitude diagram illustrating the method of dividing the sensor signal into a number of frequency bands.
Figure 6A shows a schematic block diagram of a second embodiment of the heart stimulator according to the invention.
Figure 6B shows an extracorporeal signal processing device adapted to communicate with the pacemaker according to Figure 6A.
Figure 7 is a time/amplitude diagram illustrating parameter values in the shape of sampled values indicating the temporal progression of the 50 hertz component of a sensor signal. Detailed description of the embodiments
Fig 1A shows a schematic block diagram of a first embodiment of an implantable device 10 for providing stimulation signals and for detecting signals relating to heart activity of a patient. The device 10 comprises an accelerometer 20, which is mechanically connected to the housing 30 of the stimulator 10, as will be described in detail in connection with Figures 2 and 3. The accelerometer 20 senses the vibrations of the pacemaker housing 30. The accelerometer 20 and the housing 30 functions together as a microphone for acoustic waves corresponding to heart valve sounds and heart muscle movements.
As clear from the above, the accelerometer produces an vibration signal S comprising information about the activity of the heart. According to the invention the signal is processed such that a plurality of parameter values are generated. In response to the parameter values it is possible to determine the medical status of the heart.
The accelerometer 20 supplies the vibration signal S to a processing unit 40, which includes a plurality of bandpass filters 50 for dividing the electrical signal S into a plurality of frequency bands B, - Bn, the frequency bands having the center frequency at e.g. 50, 100, 200 and 400 Hz. However other center frequencies, both higher and lower ones are possible depending on the frequency of interest. A unit 60 is arranged for measuring the energy P, - Pn in each frequency band, for generating a reference value Ptot comprising the total amount of energy calculated as the sum of P, - Pn , and for dividing each individual energy value P, - Pn with the reference value so as to achieve a number of parameter values C, - Cn. The energy values P, - Pn are sampled with a sampling frequency fs, which may be, for example, 2 kHz. Accordingly, n digital energy signals will be generated, each signal indicating the actual sensed energy within a specified frequency band.
The parameter values C, - Cn are supplied to a control unit 100 where a set of status values are determined as a quotient between two simultaneously generated parameter values. The control unit is in Fig. 1 shown as a separate unit but could as well be an integral part of the processing unit 40.
Each parameter value constitutes a value indicative of the amount of vibration of the stimulator housing in the respective frequency region. The relation between the amplitudes in two different frequency regions expressed as quotients could be set up as: Q, = CJ C2
Q2 = CV C3 where the values of Q, , Q2 etc. are indicative of the status of the heart. The parameter values forming the quotient (e.g. C, and C2) are chosen in dependence on < which conditions to be studied, e.g. valve sounds and heart muscle movements from heart tissue close to the pacemaker housing. The heart's contractility is for exemple reflected by the frequency content of the heart sound in the way that a heavier heart contraction is shown as a frequency shift towards higher frequencies.
10 The normal values for the quotients constitute reference status values in response to which a first operational mode of the heart stimulator may be suitable. Such normal values are stored in a memory means 70.
The control unit operates to monitor the new status values in realtime. By means of I ) registering a predefined deviation from the stored reference status values another operational mode for the heart stimulator can be activated. A stimulation control signal CS is generated in response to these comparisons made in the control unit 100. As indicated above the heart's contractility can be determined from the detected heart sound, and then also other parameters related to the contractility, e.g. the stroke volume, blood pressure (P) '0 and dP/dt. These parameters can be used by the control unit to decide which operational mode the heart stimulator should work in. Using one or many of these parameters as a control parameter for a pacemaker is well known by a person skilled in the art of pacemakers and is therefore not described in this application.
I ) The parameter values C, - Cn can also be supplied to the memory means 70 for storage in consecutive time order and to a limit value sensor 80. The limit value sensor 80 is operative to provide comparisons between the actual parameter values received on a first input 90 from the signal processing unit 40 with reference parameter values stored in the memory means 70. According to one version of the invention the limit value sensor 80 generates a
K) moving average value Cla - Cna of each of the parameter values C, - Cn. The moving average value is calculated as the average value for each of the parameter values during a floating time window comprising predetermined consecutive parameter values. The limit value sensor compares the actual parameter value C, with the moving average C,a and if one or several of the actual parameter values C, - Cπ deviate by more than a predetermined amount from the corresponding moving average the limit value sensor 80 generates an alarm signal L. )
The alarm signal L is supplied to an alarm transmitter 95. Alternatively the alarm signal L may be stored in the memory means 70 so as to be readable for example by means of telemetry at a later point in time when the patient visits a doctor.
10 The signal processing unit 40 also provides a continuous energy signal having an amplitude corresponding to the actual energy within each respective frequency band. Accordingly the signal processing unit provides n energy signals Pcl - Pcn to a control unit 100. The control unit 100 operates to generate a stimulation control signal in response to the energy signals. The stimulator control signal CS is provided to a stimulation signal generator 110. The
I ) signal generator 110 comprises a signal output 120 and a reference output 130. The signal output 120 is coupled to a conductor 140 in an implantable lead 150 having a tip electrode 160 which is connected to the conductor 140. The lead 150 also has a ring electrode 170 which is connected to a conductor 180 in the lead 150. The conductor 180 is coupled to the reference output 130. Accordingly the stimulator signal potential provided between
.'() terminals 120 and 130 will result in a corresponding electric potential between tip electrode 160 and ring electrode 170.
According to another version of the device according to the invention the output 120 is coupled to a lead having only one electrode and the reference terminal 130 is coupled to the housing 30 which is electrically conductive and which functions as a reference electrode. i
Referring now to Fig IB, there is shown a simplified representation of two ways that an implanted pacemaker 10 may make electrical contact with the heart of the patient. Fig IB reflects the use of a bipolar lead 150 being directed into the right atrium 190 of the heart. The distal tip electrode 160 is typically placed in a cavity of the right atrium 190 referred to
'!() as the atrial appendage 200. The housing 30 of the stimulator device 10 is substantially disc shaped with one side wall 210 positioned in the plane defined by the two orthogonal axes x and y in Fig IB. The side wall 210 has an area of preferably 500 mm2. When the stimulator 10 is implanted as shown in Fig IB such that a normal to the wall 210 is substantially directed towards the heart of the patient, as indicated by the vector z in Fig IB, the direction z coincides with the maximum sensitivity direction of the accelerometer 20.
Figs 2 and 3 show two alternative embodiments of the accelerometer 20 in the device according to the invention. Both of the shown embodiments comprise two elongated members of piezoelectric material 300 and 310 which are attached to each other and arranged in an aligned fashion next to each other so as to form an elongated sensor body. One end of the elongated sensor body is attached to the housing 30 (Fig 1A and Fig IB) by fastening means 320. The direction of elongation of the elongated sensor body 300. 310 is substantially parallel to the wall 210 of the housing 30. The elongated sensor body also has a moveable end 325, which is provided with a weight 330. Since the sensor body is attached to the housing 30 only at the one end the inertia of the weight 330 will cause the sensor body to bend in response to accelerations of the housing 30. Accordingly, when the stimulator device is implanted in the body of the patient in a manner shown in Fig IB the free end 325 of the sensor body will move in a direction substantially parallel with the direction of the normal z to the surface of the wall 210.
The elongated members 300 and 310 are polarized in substantially opposing directions as indicated by arrows 340 and 350 in Fig 2. When the sensor body moves as described above an electrical signal S is provided between terminals 360 and 370.
According to the alternative embodiment of the accelerometer 20 (Fig.3) the two elongated elements 300 and 310 are polarized in the same direction as indicated by arrows 380 and 390. A first electric sensor signal is provided between terminals U3 and U4 while a second electric signal is provided between terminals U4 and U5. By means of an adding amplifyer or other suitable means the two signals are transformed into one sensor signal S.
The electrical vibration signal S is divided into one signal for each frequency band as described above. The accelerometer shown in Figs 2 and 3 has a sensitivity of about 100 millivolts per g, that is roughly 10 millivolts per ms'2 for vibrations having a frequency between 20 hertz and 600 hertz. A typical frequency response curve for an accelerometer according to Fig 2 is shown in Fig 4. ')
Locating the accelerometer 20 in contact with the housing 30 enables the accelerometer to provide a sensor signal in response to the movements of the stimulator 10. This means that the vibration signal S depends on the vibrations of the heart stimulator 10.
10 The stimulation device 10, when implanted, functions to measure the activity of the heart of the patient by sensing mechanical vibrations transmitted by body tissue to the housing of the device 10. A fundamental problem related to all measurements is to minimize the influence of the measurement tool on the object to be measured. The inventor realized that in the case of accurately measuring vibrations in body tissue, this problem is transformed
1 into the problem of providing a device having a housing with shape, size and weight such that damping of the vibrations is minimized.
Tests for determining the influence of the weight of the stimulator 10 on the sensitivity indicate that when the weight of the stimulator 10 is below 50 grams the sensitivity reaches '0 acceptable values. The sensitivity is particularly favourable when the weight of the stimulator 10 is below 20 grams. According to a preferred embodiment of the invention the stimulator 10 has a weight W in the range from 13 to 17 grams.
Tests for determining the influence of the disc-shaped side wall area of the stimulator 10 on ϊ~) the sensitivity indicate that when the side wall area of the stimulator 10 is below 1500 mm2 for adults the sensitivity reaches favourable values. The measurement sensitivity to high frequency vibrations, i.e. above 400 Hz, increases when the side wall area is decreased. According to a preferred embodiment the stimulator device 10 has a side wall area of 500 mm2 for adults. The results of the tests indicate that the vibration signal S is advantageously accurate when the quotient of the weight W and the side wall area has a value below 0.05 g/mm2. for adults provided that the side wall area is kept below 1000 mm2.
As described above referring to Fig 1 , a plurality of bandpass filters 50 are used for dividing the vibration signal S into a plurality of indicator signals S, - Sn. Each indicator signal has a bandwidth corresponding to the three dB bandwidth of the corresponding bandpass filter. In Fig 5 the full lines illustrates the frequency response for the filters FI - Fn, having bandwidths B, - Bn. The number of frequency bands is arbitrary but there should be at least three frequency bands. All frequency bands are within the frequency range where vibration signals are related to heart sound. According to a preferred embodiment the frequency range of the vibration signal S is between 0.2 hertz to 1000 hertz.
A block diagram of a pacemaker body including electronic circuitry in accordance with a second preferred embodiment of the invention is shown in Figure 6A. The pacemaker 10 comprises a hermetically sealed housing 30. The pacemaker includes among other things a microprocessor 400 which is coupled to a read only memory, ROM, 410 and a read/write- memory. RAM, 420 via data busses 430, 440 and address busses 450, 460. There is also a lead 470 from the microprocessor 400 to the RAM 420 for setting the RAM 420 in a selected write mode or a selected read mode. A computer program is stored in the ROM 410. and by means of this program the function of the pacemaker 10 is controlled. When, in the following, it is stated that the microprocessor 400 executes a certain function it is to be understood that the microprocessor executes a certain part of the program stored in the memory 410 using data stored in the memory 420.
'->•
A clock signal generator 480 provides a clock signal to the microprocessor and also thereby provides a time reference for the pacemaker. The microprocessor 400 comprises a plurality of input/output terminals 490 coupled to two signal channels 500, 510. The channel 500 is an output channel suitable for providing stimulation pulses to the heart. The channel 500 'SO comprises a stimulation pulse generator 512 having an output U,. The pulse generator 512 is coupled to a corresponding output from the microprocessor 400 via a conductor 520, and the pulse generator 512 is arranged to produce a stimulation pulse in response to a signal provided from the output of the microprocessor. Digital data for determining for example the shape of the stimulation pulse, such as the amplitude and the duration is provided to the pulse generator 512 via a lead 530 from the microprocessor 400.
5 The channel 510 comprises an analogue-to-digital (A/D) signal converter 540 having an input I, for receiving an electrical signal corresponding to a detectable activity from the accelerometer 20. The output of the A/D converter provides a digital signal Sd which is provided to a corresponding input of the microprocessor 400 via a databus.
10 The pacemaker 10 also comprises a first connector means having a socket 550 for mating with a corresponding second connector means provided at one end of an implantable lead, such as the above described lead 150, see Fig IB. The socket 550 comprises a pin socket 560 and a connector ring 570.
1 :") The microprocessor 400 is coupled to a telemetric device 600 capable of transmitting and receiving data. The telemetric device 600 comprises an antenna 610 for communicating with a corresponding extracorporeal telemetric device.
Figure 6B shows an extracorporeal data processing arrangement having an antenna 620 10 coupled to a telemetric device 630 for enabling communication with an implanted telemetric device such as the above described device 600. The telemetric device 630 is coupled to a computer unit 640 comprising a data processing unit 650, an input/output device 660. such as a keyboard, and an output device 670 such as a screen.
~5 By means of executing a fourier transform of the input signal Sd the microprocessor can establish an amplitude value for a chosen frequency at a particular point in time.
According to the second preferred embodiment the microprocessor establishes a set of such amplitude values at consecutive points of time (t=l,2,...N) for the 50 hertz component of :jθ the signal Sd. These consecutive values are represented in fig 7 as V, 50, V2 50, V3 50, V4 50 ... VN 50. In the same manner, a set of amplitude values are established for the same points of time for the following frequency components: 100, 200 and 400 hertz.
Hence, digital representations of the 50, 100, 200 and 400 signal components are generated. ')
Each amplitude value constitutes a parameter value indicative of the amount of vibration of the stimulator housing in the respective frequency region. When for exemple the heart of the patient is healthy there is a certain relation between the amplitudes in two different frequency regions. Accordingly a typical value for the quotient
I " 1 :400.50 = * 1,40</ * 1,50 when the patient's heart is healthy will be altered to another value indicative of different heart conditions, e.g. valve sounds and heart muscle movements from heart tissue close to the pacemaker housing, if the patient's heart condition changes.
1 The normal values for the quotients constitute reference status values in response to which a first operational mode of the heart stimulator may be suitable. Such normal values are stored in the memory means 410 or 420, see Fig 6A.
The processor operates to monitor the new status values in realtime. By means of .' , ' registering a predefined deviation from the stored reference status values another operational mode for the heart stimulator can be activated.
By means of the telemetric device 600, 610 the registered status values may be transmitted to the extracorporeal data processing arrangement 640, cf. Fig 6B. The parameter values ) and the status values may be a useful information for helping a doctor in establishing the type of heart condition of a patient.
A person skilled in the art will appreciate that the present invention can be practised by other than the described embodiments, which are presented for purposes of illustration, and °;0 the present invention is limited only by the claims which follow.

Claims

Claims
1. An implantable medical device comprising a housing (30) and an accelerometer means (20) adapted for detecting vibrations of said housing, said accelerometer means (20) generating a vibration signal (S, Sd) in ) response to said detected vibrations; a signal processing unit (40; 400) having at least one input for receiving the vibration signal (S, Sd), and at least one output for providing status values (Q,,Q2 ... QN) related to predetermined heart activity; said vibration signal having an amplitude and a frequency characterised in that 10 the signal processing unit (40; 400) is set up to simultaneously generate for each of at least two defined frequency ranges (B„ B2 ...BN) a parameter value (C„ C2 ... CN ; V, 50... V, 400) indicative of a defined quantity of the vibration signal; the signal processing unit further being set up to determine at least one status value (Q,,Q2 ... QN) determined by the quotient between two parameter values (C,, C, ... CN ; V, 50
1 ... v 00).
2. An implantable medical device according to claim 1 characterised in that said defined quantity is the amplitude or the relative amplitude of the vibration signal.
'0 3. An implantable medical device according to claim 1 characterised in that said defined quantity is the energy, or the relative energy of the vibration signal.
4. A device according to one of the preceeding claims, characterised in that the signal processing unit is set up to generate status values at consecutive points in time such
'? ) that a representation of the temporal progression of each status value is generated.
5. A device according to any one of the preceeding claims, characterised in that the device further comprises a memory means for storing parameter values and/or status values such that said status values are retrievable.
6. A device according to any of claims 1 to 5, characterised in that said device has a weight equal or below 20 grams.
7. A device according to any of claims 1 to 6, characterised in that said device has a weight in the range from 10 grams to 20 grams.
ό 8. A device according to any of the preceding claims, characterised in that said accelerometer means has a first direction of sensitivity substantially perpendicular to a side wall of said housing portion (210).
9. A device according to claim 8, characterised in that the accelerometer means includes 0 a sensor body (300) having a first portion which is mechanically connected to the housing, and second portion which is provided with a mass means (330) for deforming the sensor body in response to inertia force, said sensor body delivering electrical signals in response to deformations.
5 10. A device according to claim 9, characterised in that the sensor body is an elongated body, one end portion of which constitutes the first portion, the other end portion of which constitutes the second portion, wherein the body including at least one polarized piezoelectric transducer means (300. 310) extending along the sensor body.
() 1 1. A device according to any of claims 8-10 characterised in that the housing has a side wall area being less than 1500 mm2, preferably in the range from 250 mm2 to 1000 mm2.
12. A device according to any of the preceding claims, characterised in that the quotient between the weight of the device and the side wall area is below 0.05 g/ mm2. ")
13. A device according to any of the preceding claims, characterised in that said device includes means (110) responsive to the status values for generating stimulation signals, and electrode means (150) for supplying the stimulation signals to tissue to be stimulated.
14. A heart stimulator (10) according to any one of the preceding claims, characterised in that said heart stimulator including means (80,100,400) for monitoring the status value; and means (110,512) for selectively generating stimulation signals in response to a recorded deviation of the status value from a reference value.
PCT/SE1997/001580 1996-09-30 1997-09-19 An implantable medical device comprising an accelerometer WO1998014239A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP97943257A EP0936936B1 (en) 1996-09-30 1997-09-19 An implantable medical device comprising an accelerometer
US09/147,999 US6044299A (en) 1996-09-30 1997-09-19 Implantable medical device having an accelerometer
DE69726447T DE69726447T2 (en) 1996-09-30 1997-09-19 IMPLANTABLE MEDICAL DEVICE WITH ACCELERATION SENSOR

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603573A SE9603573D0 (en) 1996-09-30 1996-09-30 Implantable medecal device
SE9603573-8 1996-09-30

Publications (1)

Publication Number Publication Date
WO1998014239A1 true WO1998014239A1 (en) 1998-04-09

Family

ID=20404081

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1997/001580 WO1998014239A1 (en) 1996-09-30 1997-09-19 An implantable medical device comprising an accelerometer

Country Status (5)

Country Link
US (1) US6044299A (en)
EP (1) EP0936936B1 (en)
DE (1) DE69726447T2 (en)
SE (1) SE9603573D0 (en)
WO (1) WO1998014239A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042089A1 (en) * 2003-10-31 2005-05-12 Sunshine Heart Company Pty Ltd Synchronisation control system
US8425397B2 (en) 2003-10-31 2013-04-23 Sunshine Heart Company Pty Ltd Percutaneous gas-line
US8469873B2 (en) 2003-10-30 2013-06-25 Sunshine Heart Company Pty Ltd Blood vessel wrap
US8702583B2 (en) 2003-11-11 2014-04-22 Sunshine Heart Company Pty, Ltd. Actuator for a heart assist device
US9042979B2 (en) 2010-04-02 2015-05-26 Sunshine Heart Company Pty Limited Combination heart assist systems, methods, and devices
US9555176B2 (en) 2002-11-15 2017-01-31 Sunshine Heart Company Pty, Ltd. Implantable device utilizing arterial deformation

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722766D0 (en) 1997-10-28 1997-12-24 British Telecomm Portable computers
US6453201B1 (en) 1999-10-20 2002-09-17 Cardiac Pacemakers, Inc. Implantable medical device with voice responding and recording capacity
US6477406B1 (en) * 1999-11-10 2002-11-05 Pacesetter, Inc. Extravascular hemodynamic acoustic sensor
US6411849B1 (en) * 1999-12-08 2002-06-25 Pacesetter, Inc. Implatable electrical device incorporating a magnetoresistive-based motion sensor
US6430440B1 (en) * 1999-12-08 2002-08-06 Pacesetter, Inc. Magnetoresistive-based position sensor for use in an implantable electrical device
US6650940B1 (en) * 2000-02-02 2003-11-18 Cardiac Pacemakers, Inc. Accelerometer-based heart sound detection for autocapture
EP1142608A2 (en) 2000-04-05 2001-10-10 Pacesetter, Inc. System and method for prevention of recurrent vasovagal syncope using cardiac pacing
US7688306B2 (en) 2000-10-02 2010-03-30 Apple Inc. Methods and apparatuses for operating a portable device based on an accelerometer
US6520013B1 (en) * 2000-10-02 2003-02-18 Apple Computer, Inc. Method and apparatus for detecting free fall
US7052466B2 (en) 2001-04-11 2006-05-30 Cardiac Pacemakers, Inc. Apparatus and method for outputting heart sounds
US6907289B2 (en) 2001-11-20 2005-06-14 Cardiac Pacemakers, Inc. Triggered storage of diagnostic data associated with compromised resynchronization therapy
US6973349B2 (en) 2001-12-05 2005-12-06 Cardiac Pacemakers, Inc. Method and apparatus for minimizing post-infarct ventricular remodeling
US20040122294A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management with environmental data
US8391989B2 (en) 2002-12-18 2013-03-05 Cardiac Pacemakers, Inc. Advanced patient management for defining, identifying and using predetermined health-related events
US7113825B2 (en) * 2002-05-03 2006-09-26 Cardiac Pacemakers, Inc. Method and apparatus for detecting acoustic oscillations in cardiac rhythm
US7123962B2 (en) * 2002-12-02 2006-10-17 Cardiac Pacemakers, Inc. Phonocardiographic image-based atrioventricular delay optimization
US7930019B2 (en) * 2002-12-02 2011-04-19 Cardiac Pacemakers, Inc. Method and apparatus for phonocardiographic image acquisition and presentation
US7260429B2 (en) * 2002-12-02 2007-08-21 Cardiac Pacemakers, Inc. Method and apparatus for phonocardiographic image acquisition and presentation
US8712549B2 (en) * 2002-12-11 2014-04-29 Proteus Digital Health, Inc. Method and system for monitoring and treating hemodynamic parameters
US7972275B2 (en) * 2002-12-30 2011-07-05 Cardiac Pacemakers, Inc. Method and apparatus for monitoring of diastolic hemodynamics
US8951205B2 (en) 2002-12-30 2015-02-10 Cardiac Pacemakers, Inc. Method and apparatus for detecting atrial filling pressure
JP4465349B2 (en) * 2003-01-24 2010-05-19 プロテウス バイオメディカル インコーポレイテッド Method and system for measuring cardiac parameters
US7610088B2 (en) * 2003-02-28 2009-10-27 Medtronic, Inc. Method and apparatus for assessing left ventricular function and optimizing cardiac pacing intervals based on left ventricular wall motion
US7092759B2 (en) 2003-07-30 2006-08-15 Medtronic, Inc. Method of optimizing cardiac resynchronization therapy using sensor signals of septal wall motion
US7248923B2 (en) 2003-11-06 2007-07-24 Cardiac Pacemakers, Inc. Dual-use sensor for rate responsive pacing and heart sound monitoring
US7215997B2 (en) * 2003-12-22 2007-05-08 Cardiac Pacemakers, Inc. Dynamic device therapy control for treating post myocardial infarction patients
US7431699B2 (en) 2003-12-24 2008-10-07 Cardiac Pacemakers, Inc. Method and apparatus for third heart sound detection
US7115096B2 (en) * 2003-12-24 2006-10-03 Cardiac Pacemakers, Inc. Third heart sound activity index for heart failure monitoring
US7209786B2 (en) * 2004-06-10 2007-04-24 Cardiac Pacemakers, Inc. Method and apparatus for optimization of cardiac resynchronization therapy using heart sounds
US7480528B2 (en) * 2004-07-23 2009-01-20 Cardiac Pacemakers, Inc. Method and apparatus for monitoring heart failure patients with cardiopulmonary comorbidities
US7559901B2 (en) 2004-07-28 2009-07-14 Cardiac Pacemakers, Inc. Determining a patient's posture from mechanical vibrations of the heart
EP1799101A4 (en) * 2004-09-02 2008-11-19 Proteus Biomedical Inc Methods and apparatus for tissue activation and monitoring
US20080058656A1 (en) * 2004-10-08 2008-03-06 Costello Benedict J Electric tomography
EP1799113A4 (en) * 2004-10-08 2010-07-07 Proteus Biomedical Inc Continuous field tomography
US7925329B2 (en) * 2004-10-08 2011-04-12 Proteus Biomedical, Inc. Implantable doppler tomography system
US20060161211A1 (en) * 2004-12-31 2006-07-20 Todd Thompson Implantable accelerometer-based cardiac wall position detector
US7662104B2 (en) 2005-01-18 2010-02-16 Cardiac Pacemakers, Inc. Method for correction of posture dependence on heart sounds
US7837634B2 (en) * 2005-03-03 2010-11-23 Proteus Biomedical, Inc. Fiberoptic tissue motion sensor
JP5027797B2 (en) * 2005-03-31 2012-09-19 プロテウス バイオメディカル インコーポレイテッド Automatic optimization of multi-electrode pacing for cardiac resynchronization
US7404802B2 (en) * 2005-05-05 2008-07-29 Cardiac Pacemakers, Inc. Trending of systolic murmur intensity for monitoring cardiac disease with implantable device
US7424321B2 (en) * 2005-05-24 2008-09-09 Cardiac Pacemakers, Inc. Systems and methods for multi-axis cardiac vibration measurements
US8972002B2 (en) 2005-06-01 2015-03-03 Cardiac Pacemakers, Inc. Remote closed-loop titration of decongestive therapy for the treatment of advanced heart failure
US7670298B2 (en) * 2005-06-01 2010-03-02 Cardiac Pacemakers, Inc. Sensing rate of change of pressure in the left ventricle with an implanted device
US7922669B2 (en) 2005-06-08 2011-04-12 Cardiac Pacemakers, Inc. Ischemia detection using a heart sound sensor
US8140158B2 (en) * 2005-06-16 2012-03-20 St. Jude Medical Ab Heart monitoring device and a system to detect vibrations concerning the status of the heart
EP1898999A4 (en) * 2005-07-01 2011-10-19 Proteus Biomedical Inc Deployable epicardial electrode and sensor array
US7585279B2 (en) * 2005-07-26 2009-09-08 Cardiac Pacemakers, Inc. Managing preload reserve by tracking the ventricular operating point with heart sounds
CN101227948A (en) * 2005-08-08 2008-07-23 杰斐逊·J·凯蒂姆斯 Method and apparatus for producing therapeutic and diagnostic stimulation
WO2007021804A2 (en) * 2005-08-12 2007-02-22 Proteus Biomedical, Inc. Evaluation of depolarization wave conduction velocity
US7634309B2 (en) * 2005-08-19 2009-12-15 Cardiac Pacemakers, Inc. Tracking progression of congestive heart failure via a force-frequency relationship
US20110066057A1 (en) * 2005-10-31 2011-03-17 Zdeblick Mark J Electrical Angle Gauge
US20070167758A1 (en) * 2005-11-23 2007-07-19 Costello Benedict J Automated detection of cardiac motion using contrast markers
US8108034B2 (en) 2005-11-28 2012-01-31 Cardiac Pacemakers, Inc. Systems and methods for valvular regurgitation detection
EP1968693A4 (en) * 2005-12-22 2011-04-27 Proteus Biomedical Inc Implantable integrated circuit
US20070161894A1 (en) * 2005-12-23 2007-07-12 Mark Zdeblick Ultrasound synchrony measurement
US7780606B2 (en) 2006-03-29 2010-08-24 Cardiac Pacemakers, Inc. Hemodynamic stability assessment based on heart sounds
US8000780B2 (en) * 2006-06-27 2011-08-16 Cardiac Pacemakers, Inc. Detection of myocardial ischemia from the time sequence of implanted sensor measurements
US20080091239A1 (en) * 2006-10-16 2008-04-17 St. Jude Medical Ab Cardiac assist device and method using epicardially placed microphone
US20080119749A1 (en) 2006-11-20 2008-05-22 Cardiac Pacemakers, Inc. Respiration-synchronized heart sound trending
US8096954B2 (en) * 2006-11-29 2012-01-17 Cardiac Pacemakers, Inc. Adaptive sampling of heart sounds
US7736319B2 (en) * 2007-01-19 2010-06-15 Cardiac Pacemakers, Inc. Ischemia detection using heart sound timing
US20080208068A1 (en) * 2007-02-26 2008-08-28 Timothy Robertson Dynamic positional information constrained heart model
US20080242976A1 (en) * 2007-03-30 2008-10-02 Proteus Biomedical, Inc. Electric field tomography
US7853327B2 (en) 2007-04-17 2010-12-14 Cardiac Pacemakers, Inc. Heart sound tracking system and method
WO2009009746A1 (en) * 2007-07-11 2009-01-15 Proteus Biomedical, Inc. Spread spectrum electric tomography
WO2009131749A2 (en) * 2008-02-28 2009-10-29 Proteus Biomedical, Inc. Integrated circuit implementation and fault control system, device, and method
WO2009140291A2 (en) * 2008-05-13 2009-11-19 Proteus Biomedical, Inc. Continuous field tomography systems and methods of using the same
WO2009158601A2 (en) * 2008-06-27 2009-12-30 Proteus Biomedical, Inc. Clinical applications for electrical tomography derived metrics
EP2358275A2 (en) * 2008-12-02 2011-08-24 Proteus Biomedical, Inc. Optimial drive frequency selection in electrical tomography
WO2010065465A2 (en) * 2008-12-02 2010-06-10 Proteus Biomedical, Inc. Analyzer compatible communication protocol
US8241221B2 (en) * 2009-02-05 2012-08-14 Pacesetter, Inc. Systems and methods for use with an implantable medical device for detecting stroke based on electrocardiac signals
US8392340B2 (en) * 2009-03-13 2013-03-05 Apple Inc. Method and apparatus for detecting conditions of a peripheral device including motion, and determining/predicting temperature(S) wherein at least one temperature is weighted based on detected conditions
EP2414036A4 (en) * 2009-04-02 2013-02-20 Proteus Digital Health Inc Method and apparatus for implantable lead
EP2424588A4 (en) * 2009-04-29 2013-05-22 Proteus Digital Health Inc Methods and apparatus for leads for implantable devices
GB0908506D0 (en) * 2009-05-18 2009-06-24 Imagination Tech Ltd Method and apparatus for drawing polygons
WO2011011736A2 (en) 2009-07-23 2011-01-27 Proteus Biomedical, Inc. Solid-state thin film capacitor
US8301267B2 (en) * 2009-09-18 2012-10-30 Cardiac Pacemakers, Inc. Method and apparatus for sensing mechanical energy of an implantable lead
US8467864B2 (en) 2010-03-11 2013-06-18 Pacesetter, Inc. Systems and methods for use by an implantable medical device for detecting and discriminating stroke and cardiac ischemia using electrocardiac signals and hemodynamic parameters
US8843197B2 (en) * 2011-03-16 2014-09-23 Pacesetter, Inc. Method and system to correct contractility based on non-heart failure factors
US8989852B2 (en) 2011-08-10 2015-03-24 Pacesetter, Inc. Systems and methods for use by implantable medical devices for detecting and discriminating stroke and cardiac ischemia using electrocardiac signals
US8768461B2 (en) 2011-09-06 2014-07-01 Pacesetter, Inc. Systems and methods for controlling paired pacing interpulse intervals to reduce contractility disequilibrium using an implantable medical device
EP2586492B1 (en) 2011-10-24 2014-06-18 St. Jude Medical AB Pacing sequence optimization
US9101275B2 (en) 2013-03-14 2015-08-11 Cardiac Pacemakers, Inc. Determining systolic time intervals using heart sounds
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140132A (en) * 1978-03-23 1979-02-20 Dahl Joseph D Variable rate timer for a cardiac pacemaker
US5383473A (en) * 1993-05-10 1995-01-24 Pacesetter, Inc. Rate-responsive implantable stimulation device having a miniature hybrid-mountable accelerometer-based sensor and method of fabrication
US5496352A (en) * 1994-04-04 1996-03-05 Pacesetter, Inc. Activity sensors for implantable medical devices

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506791A1 (en) * 1985-02-22 1986-08-28 Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin HEART PACEMAKER WITH PHYSIOLOGICAL CONTROL
US5649968A (en) * 1995-11-14 1997-07-22 Intermedics, Inc. Accelerometer-based rate-adaptive cardiac pacing with second generation signal processing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140132A (en) * 1978-03-23 1979-02-20 Dahl Joseph D Variable rate timer for a cardiac pacemaker
US5383473A (en) * 1993-05-10 1995-01-24 Pacesetter, Inc. Rate-responsive implantable stimulation device having a miniature hybrid-mountable accelerometer-based sensor and method of fabrication
US5496352A (en) * 1994-04-04 1996-03-05 Pacesetter, Inc. Activity sensors for implantable medical devices

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9555176B2 (en) 2002-11-15 2017-01-31 Sunshine Heart Company Pty, Ltd. Implantable device utilizing arterial deformation
US8469873B2 (en) 2003-10-30 2013-06-25 Sunshine Heart Company Pty Ltd Blood vessel wrap
WO2005042089A1 (en) * 2003-10-31 2005-05-12 Sunshine Heart Company Pty Ltd Synchronisation control system
US7765003B2 (en) 2003-10-31 2010-07-27 Sunshine Heart Pty Ltd Synchronization control system
CN1874821B (en) * 2003-10-31 2011-06-01 阳光心脏有限公司 Method and device for controlling operation of pacing heart auxiliary device
US8425397B2 (en) 2003-10-31 2013-04-23 Sunshine Heart Company Pty Ltd Percutaneous gas-line
US9119908B2 (en) 2003-10-31 2015-09-01 Sunshine Heart Company Pty. Ltd. Synchronization control system
US9561375B2 (en) 2003-10-31 2017-02-07 Sunshine Heart Company Pty, Ltd. Synchronization control system
US8702583B2 (en) 2003-11-11 2014-04-22 Sunshine Heart Company Pty, Ltd. Actuator for a heart assist device
US9042979B2 (en) 2010-04-02 2015-05-26 Sunshine Heart Company Pty Limited Combination heart assist systems, methods, and devices

Also Published As

Publication number Publication date
US6044299A (en) 2000-03-28
SE9603573D0 (en) 1996-09-30
DE69726447T2 (en) 2004-08-26
EP0936936B1 (en) 2003-11-26
DE69726447D1 (en) 2004-01-08
EP0936936A1 (en) 1999-08-25

Similar Documents

Publication Publication Date Title
EP0936936B1 (en) An implantable medical device comprising an accelerometer
CN109890458B (en) Implantable medical device with pressure sensor
US5425750A (en) Accelerometer-based multi-axis physical activity sensor for a rate-responsive pacemaker and method of fabrication
US6937899B2 (en) Ischemia detection
EP1660178B1 (en) Optimization of cardiac resynchronization therapy using sensor signals of septal wall motion
US6860857B2 (en) Implantable intravascular pressure determining device and method
US6449508B1 (en) Accelerometer count calculation for activity signal for an implantable medical device
EP1423163B1 (en) System for detecting myocardial ischemia
US20030158492A1 (en) Ischemia detection
EP0727242A2 (en) Motion sensor for implantable medical device
US20090306736A1 (en) Accelerometer-based monitoring of the frequency dynamics of the isovolumic contraction phase and pathologic cardiac vibrations
US20210308467A1 (en) Implantable medical device with pressure sensor
WO2009045811A1 (en) Method and apparatus to perform transvascular hemodynamic sensing
US8140158B2 (en) Heart monitoring device and a system to detect vibrations concerning the status of the heart

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997943257

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998516425

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09147999

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1997943257

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1997943257

Country of ref document: EP